AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Cognipride-MV2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Cognitive Life Sciences Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Cognipride-MV2 Tablet SR

Diabetace-Duo SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This medication helps regulate blood glucose. Diabetace-Duo SR should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue this medication even with controlled blood sugar; discontinuation without consulting your doctor can elevate blood sugar, risking kidney complications, vision loss, neuropathy, and limb loss. This treatment necessitates a comprehensive approach incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize its symptoms—sweating, dizziness, headache, tremors—and how to manage them. Regular meals and readily available glucose sources (sugary foods or juice) are crucial. Alcohol consumption increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is a potential consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your physician of any prior heart conditions before starting treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Cognipride-MV2 Tablet SR

No text provided to rephrase.

Uses of Cognipride-MV2 Tablet SR

Managing type 2 diabetes

Major Benefits of Cognipride-MV2 Tablet SR:

Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the Cognipride-MV2 Tablet SR whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.

Common Side effects of Cognipride-MV2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Cognipride-MV2 Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Cognipride-MV2 Tablet SR whole; avoid chewing, crushing, or fracturing it. Consume it on an empty stomach.

How Cognipride-MV2 Tablet SR works:

Cognipride-MV2 Extended-Release tablets contain a triple-action formulation to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Cognipride-MV2 SR tablets is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Cognipride-MV2 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Cognipride-MV2 Tablet SR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Employing Cognipride-MV2 Tablet SR carries a high likelihood of risk for individuals with kidney impairment and should be omitted. Seek medical advice before use. Furthermore, its use is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Exercise caution when prescribing Cognipride-MV2 Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. A reduced initial dose of Cognipride-MV2 Tablet SR is typically warranted for patients exhibiting mild to moderate liver dysfunction; its administration is contraindicated in those with severe liver disease.

What if you forget to take Cognipride-MV2 Tablet SR :

Should you forget a Cognipride-MV2 Tablet SR dose, take it immediately if possible. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Cognipride-MV2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Cognipride-MV2 Tablet SR

Cognipride-MV2 SR tablets combine glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This medication is not suitable for type 1 diabetes.
Cognipride-MV2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infections.
Cognipride-MV2 Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Cognipride-MV2 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Cognipride-MV2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and keep it out of reach of children, pets, and others.
Cognipride-MV2 Tablet SR
123
MRP 150
18% off